securities fraud

Schall Law Firm sues Ramaco Resources for allegedly making false statements about Brook Mine operations, affecting investors who purchased stock between July-October 2025.

Schall Law Firm launches class action against Beyond Meat for allegedly issuing false statements about asset valuations, affecting shareholders from February-November 2025.

Schall Law Firm launches securities fraud class action against Vistagen for allegedly making misleading statements about fasedienol drug trial prospects, affecting investors from April 2024 to December 2025.

Class action lawsuit filed against Smart Digital Group for allegedly failing to disclose material risks, market manipulation, and insider sales between May-September 2025.

Class action lawsuit filed against Ramaco Resources for allegedly making false statements about mining operations at Brook Mine facility, causing investor damages.

Varonis Systems faces class action lawsuit alleging false statements about SaaS conversion capabilities, causing artificially inflated stock prices between February-October 2025.

Class action lawsuit filed against Klarna alleging its September 2025 IPO registration statement contained material misstatements about financial risk exposure and buy-now-pay-later loan portfolio risks.

Sallie Mae faces class action lawsuit for allegedly failing to disclose rising loan delinquencies and overstating loss mitigation effectiveness, misleading investors about financial health.

Mereo BioPharma faces class action lawsuit over allegedly misleading disclosures about failed Phase 3 clinical trials. Investors claim the company concealed negative trial results.

Class action lawsuit filed against Ardent Health for allegedly misrepresenting accounting practices and collection methodologies to investors between July 2024 and November 2025.

Beyond Meat faces shareholder class action over alleged undisclosed asset impairment charges. Investors who bought stock Feb-Nov 2025 can join litigation by March 24, 2026.

Schall Law Firm launches class action against Charming Medical (MCTA) after SEC suspended trading following alleged market manipulation through social media promotion.

Class action filed against Charming Medical for alleged stock price manipulation through coordinated social media promotion. Trading suspended pending SEC investigation.

Ultragenyx faces securities lawsuit alleging misleading claims about setrusumab's efficacy. Investors must act by April 6, 2026 deadline to join class action.

Rosen Law Firm sues BlackRock TCP Capital for allegedly making false statements about investment valuations and net asset values, inflating security prices. Lead plaintiff deadline: April 6, 2026.

Class action lawsuit filed against China Liberal Education for alleged social media fraud scheme that artificially inflated stock price, causing investor losses when stock collapsed January 30.